2020-02-20 | Vator Securities: Ascelia Pharma: A rocket roll out is the key to success Download Presentation Webcast Excel
Regulatory 2020-02-19 | First patient enrolled in pivotal Phase III clinical study SPARKLE with lead candidate Mangoral Download Presentation Webcast Excel
Regulatory 2020-02-14 | 2019 year-end financial report: Sites opened for recruitment to the pivotal Phase III study SPARKLE Download Presentation Webcast Excel
2020-02-11 | Ascelia Pharma wins the award for Best Life Science company in Malmö Download Presentation Webcast Excel
Regulatory 2020-01-13 | Five sites now opened in the pivotal Phase III clinical study SPARKLE for lead drug candidate Mangoral Download Presentation Webcast Excel
